Tag: Boston
GSK to acquire vaccine developer Affinivax in deal worth up to $3.3bn
GlaxoSmithKline (GSK) has agreed to acquire Affinivax, a Boston-based clinical-stage vaccine developer, in a deal worth up to $3.3 billion. The consideration includes an upfront ... Read More
Lilly to open $700m Lilly Institute for Genetic Medicine in Boston
Eli Lilly and Company (Lilly) has revealed plans to open a new research facility for genetic medicine dubbed as Lilly Institute for Genetic Medicine in ... Read More
Li-Metal battery manufacturer SES AI creates subsidiary in South Korea
SES AI Corporation, a Boston-based battery technology company, has formed a subsidiary called SES Korea with intentions to construct a pre-production facility in South Korea. ... Read More
One80 Intermediaries acquires workers’ compensation broker PMC Insurance
One80 Intermediaries, a Boston-based specialty insurance broker, has acquired PMC Insurance Group, a wholesale broker for workers’ compensation and program manager. The financial terms of ... Read More
Recruiting software firm Bullhorn buys cube19 business intelligence platform
Bullhorn, a Boston-based cloud computing company that offers software for the staffing industry, has acquired cube19 for an undisclosed price. cube19 is a business intelligence ... Read More
Accenture buys procurement spend management specialist ClearEdge Partners
Accenture has acquired ClearEdge Partners, a Boston-based company that specializes in procurement spend management, for an undisclosed price. ClearEdge Partners is said to enable its ... Read More
Adidas to sell Reebok to Authentic Brands Group in $2.1bn deal
German sportswear manufacturer Adidas has agreed to sell American footwear and clothing brand Reebok to brand management company Authentic Brands Group (ABG) in a deal ... Read More
US biotech company Ginkgo Bioworks to merge with Soaring Eagle in $15bn deal
Ginkgo Bioworks, a Boston-based biotech company, has agreed to merge with Soaring Eagle Acquisition Corp., a publicly traded blank check company, in a deal that ... Read More
Eastern Bankshares to acquire Century Bancorp in $642m deal
Eastern Bankshares has agreed to acquire rival Boston-based bank holding company Century Bancorp in an all-cash deal worth $642 million. While Eastern Bankshares is the ... Read More
Pyxis Oncology raises $152m in Series B round for cancer therapies
Pyxis Oncology, a Boston-based biotech company, has raised $152 million in a Series B financing round co-led by Arix Bioscience and RTW Investments. The company ... Read More